Melissa P Lokugamage

About Melissa P Lokugamage

Melissa P Lokugamage, With an exceptional h-index of 16 and a recent h-index of 16 (since 2020), a distinguished researcher at Georgia Institute of Technology, specializes in the field of drug delivery, DNA barcoding, nanotechnology, gene editing, LNPs & RNA.

His recent articles reflect a diverse array of research interests and contributions to the field:

High-throughput screens identify a lipid nanoparticle that preferentially delivers mRNA to human tumors in vivo

Nanoparticle stereochemistry-dependent endocytic processing improves in vivo mRNA delivery

The Transcriptional Response to Lung-Targeting Lipid Nanoparticles in Vivo

Substituting racemic ionizable lipids with stereopure ionizable lipids can increase mRNA delivery

The extent to which lipid nanoparticles require apolipoprotein E and low-density lipoprotein receptor for delivery changes with ionizable lipid structure

Piperazine-derived lipid nanoparticles deliver mRNA to immune cells in vivo

Nanoparticle single-cell multiomic readouts reveal that cell heterogeneity influences lipid nanoparticle-mediated messenger RNA delivery

Species-dependent in vivo mRNA delivery and cellular responses to nanoparticles

Melissa P Lokugamage Information

University

Position

___

Citations(all)

1271

Citations(since 2020)

1254

Cited By

259

hIndex(all)

16

hIndex(since 2020)

16

i10Index(all)

21

i10Index(since 2020)

20

Email

University Profile Page

Google Scholar

Melissa P Lokugamage Skills & Research Interests

drug delivery

DNA barcoding

nanotechnology

gene editing

LNPs & RNA

Top articles of Melissa P Lokugamage

High-throughput screens identify a lipid nanoparticle that preferentially delivers mRNA to human tumors in vivo

Journal of Controlled Release

2023/5/1

Nanoparticle stereochemistry-dependent endocytic processing improves in vivo mRNA delivery

Nature Chemistry

2023/4

The Transcriptional Response to Lung-Targeting Lipid Nanoparticles in Vivo

Nano letters

2023/1/26

Substituting racemic ionizable lipids with stereopure ionizable lipids can increase mRNA delivery

Journal of Controlled Release

2023/1/1

The extent to which lipid nanoparticles require apolipoprotein E and low-density lipoprotein receptor for delivery changes with ionizable lipid structure

Nano Letters

2022/12/15

Piperazine-derived lipid nanoparticles deliver mRNA to immune cells in vivo

Nature Communications

2022/8/15

Nanoparticle single-cell multiomic readouts reveal that cell heterogeneity influences lipid nanoparticle-mediated messenger RNA delivery

Nature Nanotechnology

2022/8

Species-dependent in vivo mRNA delivery and cellular responses to nanoparticles

Nature nanotechnology

2022/3

Augmented lipid-nanoparticle-mediated in vivo genome editing in the lungs and spleen by disrupting Cas9 activity in the liver

Nature biomedical engineering

2022/2

A systematic analysis of biotech startups that went public in the first half of 2021

Current Research in Biotechnology

2022/1/1

Melissa P Lokugamage
Melissa P Lokugamage

H-Index: 9

Optimization of lipid nanoparticles for the delivery of nebulized therapeutic mRNA to the lungs

Nature biomedical engineering

2021/9

Therapeutic RNA delivery for COVID and other diseases

2021/8

UTILIZING HIGH-THROUGHPUT IN VIVO NANOPARTICLE SCREENS TO IMPROVE DRUG DELIVERY

2021/4/7

Multiplexed Analysis of Materials for Tissue Delivery

2020/10/22

Nanoparticles containing constrained phospholipids deliver mRNA to liver immune cells in vivo without targeting ligands

Bioengineering & translational medicine

2020/9

Mild innate immune activation overrides efficient nanoparticle‐mediated RNA delivery

Advanced materials

2020/1

Melissa P Lokugamage
Melissa P Lokugamage

H-Index: 9

Chiara Zurla
Chiara Zurla

H-Index: 17

Joel Levin
Joel Levin

H-Index: 0

See List of Professors in Melissa P Lokugamage University(Georgia Institute of Technology)

Co-Authors

academic-engine